Options Brief: Cadence Pharmaceuticals
Shares of Cadence Pharmaceuticals (NASDAQ: CADX) are lower on the session by 1.15%, trading at $8.57.
Overall call volume is now running at 5.66x the daily average, with 77% of all calls traded being purchases on the offer. 2,005 contracts have traded on the session so far.
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates for use in the hospital setting.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.